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HIV-1 LAI is a syncytium-inducing (SI) virus with a broad host cell range. We previously isolated a LAI variant that improved
replication in the SupT1 T cell line due to mutations within the C1 and C4 constant regions of the Env protein. We now report
that this variant exhibits a severely restricted host cell range, as replication in other T cell lines and primary cells was
abolished. Several Env-mediated functions were analyzed to provide a mechanistic explanation for this selective adaptation.
The change in host cell tropism was not caused by a switch to a SupT1-specific coreceptor. Biosynthesis of the variant Env
glycoprotein was not improved in SupT1 cells, and in fact a small defect in intracellular Env processing was observed. SupT1
infection assays did not reveal an improved Env function either, and a dramatic loss of infectivity was measured with other
cell types. The Env-mutated HIV-1 reached an approximately fivefold higher level of virus production in SupT1 cells at the
peak of infection. Unlike the LAI virus, the variant did not trigger the formation of syncytia. Our combined results suggest that
the HIV-1 variant allows the infected host cell to survive longer, thus producing more viral progeny. The intricate virus-cell
interaction results in a balance between optimal virus replication and host cell survival, causing a cytopathic SI isolate to
evolve toward a nonsyncytium-inducing (NSI) phenotype in cell culture. These findings may help explain the absence of SI
variants in the initial phase of HIV-1 infection, and the results dispute the notion that HIV-1 evolution should always go from
the NSI to SI phenotype. © 1999 Academic Press
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aINTRODUCTION
Primary isolates of the human immunodeficiency virus
ype 1 (HIV-1) consist of a complex, heterogeneous pop-
lation, or so-called quasispecies (Domingo and Hol-
and, 1997). The majority of isolates from infected asymp-
omatic patients replicate in macrophages, display a
onsyncytium-inducing (NSI) phenotype and generally
ail to infect established CD41 T cell lines. Primary iso-
ates that can infect and induce syncytia (SI) in the MT2
cell line can be isolated from a significant percentage
f patients that have progressed to AIDS (De Jong et al.,
992; Koot et al., 1992). HIV-1 uses the CD4 molecule as
eceptor, but coreceptors are also necessary for infec-
ion. Recent studies have indicated that the host cell
ropism of HIV-1 variants reflects the ability of the viral
nv protein to bind to a specific member of the chemo-
ine receptor family. Most macrophage-tropic isolates
se the CCR5 receptor, whereas the T-cell-tropic viruses
mploy the CXCR4 receptor (Bates, 1996; Chesebro et al.,
996; Doms and Peiper, 1997). An important difference
etween these two systems is that HIV infection of CD41
cells in vitro leads to extensive cell death, whereas HIV
nfection of monocytes/macrophages produces a more
imited cytopathicity. The dominant killing pathway for SI
iruses is syncytia-induced apoptosis, whereas NSI vari-
1 To whom reprint requests should be addressed. Fax: 31-20-
o916531. E-mail: B.Berkhout@AMC.UVA.NL.
55nts may kill host cells by an alternative mechanism
Cao et al., 1996; Kolesnitchenko et al., 1997). The HIV-1
ell tropism is not a fixed property and can change in vivo
r upon passaging of the virus in cell culture. The NSI to
I shift that is observed in some patients usually coin-
ides with a change in cell tropism and often involves
mino acid substitutions in the variable V3 loop of the
nv subunit gp120 (De Jong et al., 1992). Interestingly, an
ncrease in positive charge of this Env domain is usually
bserved that may correlate with the negative charge of
XCR4 compared with the CCR5 coreceptor (Jiang, 1997;
erkhout and Das, 1998). There are other Env determi-
ants of cell tropism however, and it is clear that the
irus-cell interaction is complex and conformational in
ature (Freed and Martin, 1995) with the participation of
ultiple regions in the viral Env protein and the cellular
D4 and coreceptor molecules.
Passage of HIV-1 in cell lines will affect the biological
roperties of the virus. Cell culture will select certain
henotypes from the quasispecies population. For exam-
le, positive selection pressure will favor variants that
re better able to bind to and enter the target cells, and
egative pressure will eliminate variants that are exces-
ively cytopathic. Prolonged culture will allow adaptation
f the virus to the particular cell line used in that exper-
ment. Such laboratory-adapted isolates can differ sub-
tantially from their progenitor patient viruses. The
dapted viruses usually grow in an expanded repertoire
f leukemic T cell lines, use the CXCR4 coreceptor, and
0042-6822/99 $30.00
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56 DAS ET AL.nduce syncytia (Peden et al., 1991; Moore and Ho, 1995;
ozak et al., 1997). In general, laboratory-adapted iso-
ates appear to be more sensitive to neutralization by a
ariety of reagents, including soluble CD4, anti-Env
onoclonal antibodies, and sera of HIV-1-infected indi-
iduals (Daar et al., 1990; Moore et al., 1995; Sullivan et
l., 1995; Wrin et al., 1995; Zhang et al., 1997). Although it
s evident that some questions should not be addressed
ith laboratory-adapted strains (e.g., vaccine tests with
eutralizing antibodies), detailed analysis of such vi-
uses may help us understand the complex interplay of
he HIV-1 Env protein with multiple cell receptors in
rocesses of virus infection and cell fusion. In this cell
ulture adaptation study, we present evidence that an SI
irus evolves into a more fit virus with an NSI phenotype.
he results suggest that HIV-1 virion production is opti-
ized indirectly through longer survival of the cells that
re infected with the adapted NSI variant.
RESULTS
he SupT1-adapted HIV-1 LAI variant
By long-term cultivation of a replication-impaired HIV-1
FIG. 1. Env mutations that improve replication of LAI and LAI-derived
onserved (C) and variable (V) regions of gp120 and the transmembr
utations in the SalI-BamHI fragment of the mutant Env protein are ind
ode) present in the LAI Env protein, the residue number, and the ami
re: I24T, T3C at nucleotide position 6327 (silent mutation in the vpu g
3A at 7870; Q557Q, G3A at 7927; A705V, C3T at 8370.utant with a translation defect (mLAI) on SupT1 cells, oe previously obtained a variant Env protein that im-
roved viral replication in these cells (Das et al., 1998).
his variant Env protein contains four amino acid
hanges (indicated as closed circles in Fig. 1) and im-
roved replication of the wild-type LAI virus (Fig. 2, top
eft, compare LAI and LAIenv, see also Das et al., 1998).
lthough the gain of replication capacity is relatively
mall, we observed the same pattern in multiple inde-
endent transfections. The increase in replication capac-
ty is more obvious when the variant Env gene is present
n the poorly replicating mLAI mutant (Fig. 2, top left,
ompare mLAI and mLAIenv). The SupT1-adapted Env
ragment was split into five subfragments (Fig. 1, frag-
ents A–E) that were introduced individually into the
LAI genome. The replication of this set of viruses was
ested in SupT1 cells (Fig. 2, top right). Fragment C with
he G436R mutation improved replication profoundly. The
fragment with the A70T mutation also improved virus
eplication but to a lesser extent. The other fragments did
ot improve viral replication. In summary, these results
ndicate that two Env amino acid changes in the C1 and
4 domains are responsible for the increased replication
s on SupT1 cells. The complete env coding region is shown with the
main (TM) of gp41. Silent (open circles) and nonsilent (filled circles)
. The mutations were named by appending the amino acid (one-letter
present in the Env revertant. The corresponding nucleotide changes
70T, G3A at 6464; Y389Y, C3T at 7423; G436R, G3A at 7562; A538A,viruse
ane do
icated
no acid
ene); Af HIV-1 in SupT1 cells.
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57LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1FIG. 2. Env mutations that stimulate replication in SupT1 cells reduce replication in other cell types. Proviral clones with a wild-type env gene (LAI
nd mLAI) or the mutant env gene (LAIenv and mLAIenv) were transfected into different cell types (left). The revertant env fragment was split into five
ubfragments (Fig.1, fragments A–E) that were used to replace the corresponding sequences in the mLAI mutant. Replication of these clones (A–E)
as assayed by transfection of different cell types (right). Note that the top right panel has been published as part of the preceding study in which
he variant Env function was selected (Das et al., 1998). We included this graph for comparison. DNA was transfected into the T-cell lines SupT1, MT-2,
8166 (all 1 mg) and A3.01 (2.5 mg), and primary PBMC (5 mg). CA-p24 levels were measured in the culture supernatant at several days
osttransfection.
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58 DAS ET AL.daptation of HIV-1 Env to SupT1 cells leads to
educed replication in other cell types
We assayed the effect of the modified Env protein on
iral replication in other T-cell lines (MT-2, C8166, A3.01)
nd peripheral blood mononuclear cells (PBMC). Repli-
ation of the LAI and mLAI viruses with the wild-type and
ariant Env fragment was compared (Fig. 2, left). The
LAI mutant demonstrated a partial replication defect in
ll these cells. Surprisingly, the new Env fragment further
educed the replication capacity of this virus. Moreover,
his Env segment also strongly interfered with replication
f the LAI virus. This inhibitory effect of the modified Env
rotein in these cells contrasts with the stimulatory effect
bserved in SupT1 cells. The cell-type-dependent effects
e observed for the complete Env fragment are summa-
ized in Table 1.
We also tested the A–E subfragments of the Env pro-
ein for their effect on replication of the mLAI virus in
ifferent cell types (Fig. 2, right). The mutant subfragment
, which was responsible for the major improvement of
eplication in SupT1 cells, also stimulated replication in
T-2 cells but reduced replication in C8166, A3.01, and
BMC. The mutant subfragment B, which demonstrated
minor stimulatory effect in SupT1 cells, stimulated
eplication in MT-2 and C8166 but reduced replication in
3.01 and PBMC. The other subfragments (A, D, and E)
emonstrated no effect on HIV-1 replication in all cell
ypes, with one exception. Subfragment E moderately
nhibited replication in A3.01 cells. These rather compli-
ated phenotypes of the Env subdomains are summa-
ized in Table 1. Despite the stimulatory effect of the B
nd C subfragments in some cell types, the combined
nv mutations reduced replication in all non-SupT1 cells.
hus these modified Env residues represent adaptations
f HIV-1 for optimal replication in SupT1 cells, and the
ombined mutations severely reduce the capacity to rep-
icate in other T-cell lines and primary T cells. Interest-
ngly, whereas only one mutation seems largely respon-
ible for improved replication in SupT1 cells (subfrag-
TABLE 1
Replication of Wild-Type and Env-Mutated HIV-1 in Different Cells
Virus cell SupT1 MT-2 C8166 A3.01 PBMC
LAI 1111 1111 1111 1111 1111
LAIenv 1111 11 2 1 2
mLAI 2 11 11 11 11
mLAIenv 111 1 2 2 2
mLAIenvA 2 11 11 11 11
mLAIenvB 1 11/111 111 1 1
mLAIenvC 111 111 1 1 1
mLAIenvD 2 11 11 11 11
mLAIenvE 2 11 11 1/11 11ent C), several mutations seem required for a complete foss of infectivity on the other cell lines. Although spec-
lative, these differences may be relevant for discerning
he mechanism(s) behind each phenotype.
nv mutations do not change the coreceptor usage
The T-cell tropic LAI virus uses the CXCR4 protein as
oreceptor for infection. Because the Env mutations may
ave resulted in the adaptation to another coreceptor
hat is specific for the SupT1 cell line, we tested the
oreceptor usage of LAIenv. We first assayed the ability of
AIenv to replicate in a set of CD4-positive human osteo-
arcoma (HOS) cells expressing different chemokine re-
eptors (CCR2b, CCR3, CCR4, CCR5, and CXCR4) (Deng
t al., 1996). However, this approach failed because LAIenv
id not replicate in any of these cells, including the
OS-CXCR4 cell line. Apparently, the Env mutations in-
erfere with virus replication in HOS cells, similar to the
ffects seen in PBMC and all T cell lines other than
upT1 (Fig. 2). We therefore used an alternative ap-
roach to test whether a coreceptor switch had taken
lace in LAIenv. The chemokine SDF-1, the natural ligand
f the CXCR4 receptor, can inhibit replication of CXCR4-
ependent HIV-1 isolates (Bleul et al., 1996; Oberlin et al.,
996). We examined the effect of SDF-1 on the replication
f LAI and LAIenv virus. SupT1 cells were infected with
wo different amounts of these viruses in the presence or
bsence of 100 nM SDF-1, and virus production was
easured after 6 days. In the absence of SDF-1, in-
reased virus production was observed for LAIenv com-
ared with LAI (compare Figs. 3A and 3B for the 5 ng
nfection and Figs. 3C and 3D for the 0.5 ng infection;
ote the differences in CA-p24 values plotted on the y
xes). This observation is consistent with the previous
esults in SupT1 cells (Fig. 2). As expected, infection and
eplication of the wild-type LAI virus was strongly inhib-
ted by SDF-1 (Figs. 3A and 3C), but a very similar pattern
as observed for LAIenv (Figs. 3B and 3D). In a control
xperiment, CCR5-using primary isolates were not found
o be sensitive to this CXCR4-specific chemokine (results
ot shown). This result strongly suggests that both LAI
nd LAIenv viruses use the CXCR4 coreceptor for infec-
ion.
nv mutations affect Env biosynthesis
The efficiency of Env protein synthesis may differ sig-
ificantly among different cell types (Koken and Berk-
out, 1994; Shahabuddin et al., 1996), and we previously
eported that intracellular trafficking of the wild-type LAI
nv protein is inefficient in SupT1 cells (Koken and Berk-
out, 1994). This raised the possibility that the observed
nv adaptation may improve this process, which should
esult in enhanced Env production. We therefore exam-
ned the effect of the mutations on Env protein synthesis.
irst, Env protein was expressed upon transient trans-ection of the CD42 C33A cervix carcinoma cell line and
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59LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1nalyzed by Western blotting with a monoclonal antibody
hat detects both gp160 precursor and processed gp120
nv proteins (Fig. 4). The wild-type LAI and translation-
mpaired mLAI constructs, both expressing the wild-type
nv protein, demonstrated a gp120 signal that is more
ntense than the gp160 precursor band. In contrast, the
atio of the two Env forms was reversed for the LAIenv and
LAIenv constructs. These results suggest that process-
ng of the gp160 precursor in these non-T cells was
ffected by the Env mutations. Despite this difference in
p160 processing, Western-blot analysis of virion parti-
les showed a similar gp120 content of wild-type and
utant virions (not shown).
To follow the fate of the wild-type and variant Env
olecules in SupT1 cells, we performed pulse–chase
abeling experiments. SupT1 cells were transfected with
LAI or pLAIenv and cultured for 2 days. The cells were
ulse-labeled with [35S]methionine/cysteine for 30 min
nd subsequently chased by addition of an excess of
nlabeled amino acids. At various times (0–16 h), cell
FIG. 3. LAI and LAIenv are similarly inhibited by the chemokine SDF-1
g CA-p24) in the presence or absence of 100 nM SDF-1 1–67 (Bleul et
upernatant at 6 days after infection.nd culture medium samples were taken. The viral pro- Eeins in both fractions were immunoprecipitated with
olyclonal antibodies present in the serum of an HIV-1-
nfected individual and analyzed by reducing denaturing
cells were infected with equal amounts of LAI or LAIenv virus (5 or 0.5
6; Oberlin et al., 1996). CA-p24 production was measured in the culture
FIG. 4. Western blot analysis of Env proteins produced in C33A cells.
33A cells were transfected with wild-type (LAI) and mutant proviral
onstructs (lane 1, LAI; lane 2, LAIenv; lane 3, mLAI; lane 4, mLAIenv). At 3
ays posttransfection, total cellular extracts were prepared and analyzed.. SupT1
al., 199nv gp160 and gp120 proteins were identified with an anti-Env MAb.
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60 DAS ET AL.olyacrylamide gel electrophoresis (Figs. 5A and 5B for
he cell and supernatant samples, respectively). Directly
fter pulse-labeling, a similar Env gp160 level was ob-
erved in the cells transfected with the wild-type LAI and
he mutant LAIenv construct (Fig. 5A, lanes 1 and 6). Due
o processing of this gp160 precursor into gp120 and
FIG. 5. Metabolic labeling of viral proteins. Two days after transfection
ith [35S]methionine/cysteine for 30 min, and labeled protein was chas
ell and culture medium samples were taken. (A and B) Viral proteins i
n the serum of an HIV-1-infected individual and analyzed by reducing S
p160 precursor and the processed gp120 Env molecules, and the
mmunoprecipitated with a gp160-specific rabbit antiserum, deglycosy
ethods, and analyzed via nonreducing (C) or reducing SDS–PAGE (Dp41, Env gp120 molecules were detectable at later time boints. The majority of LAI gp160 was cleaved into gp120
lready after a chase period of 2 h, but uncleaved LAIenv
p160 remained the most prominent form for $4 h. Ap-
arently, processing of the wild-type precursor was more
fficient than processing of the mutant protein. Process-
ng of the Gag p55 protein proceeded at a similar rate for
T1 cells with LAI or LAIenv proviral constructs, cells were pulse-labeled
dding an excess of unlabeled amino acids. At various times (0–16 h),
fractions were immunoprecipitated with polyclonal antibodies present
GE [(A) cell samples; (B) culture medium samples]. The position of the
5 protein are indicated. (C and D) Cellular Env gp160 protein was
treatment with endoglycosidase F as described underMaterials and
), Env gp160 aggregates are indicated with an asterisk (*).of Sup
ed by a
n both
DS–PA
Gag p5
lated byoth viruses, indicating that processing of the viral pro-
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61LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1eins was not affected generally for the Env-mutated
onstruct. Although the rate of processing of Env protein
as slower in LAIenv, a similar amount of Env gp120
nded up in the culture medium for the wild-type and
utant constructs (Fig. 5B). This result indicates that
ssembly of Env-containing virions was not significantly
ffected by the mutations in LAIenv. We also quantitated
he Gag p55 and Env gp120 signals to determine the ratio
f the two viral proteins in virions (not shown). We mea-
ured a similar ratio for the wild-type and mutant virus
amples, indicating that these virion particles have the
ame composition.
To investigate in more detail the biosynthetic defect of
he mutant Env protein, we analyzed the formation of
isulfide bridges in the gp160 protein. This assay is a
easure for the folding kinetics of the Env protein. To
ollow disulfide bond formation in newly synthesized Env
rotein, the immunoprecipitates first were treated with
ndoglycosidase F to increase the electrophoretic mo-
ility of the protein and then analyzed under nonreducing
onditions (Braakman et al., manuscript in preparation).
ewly synthesized Env protein has fewer disulfide bonds
han the mature, folded Env protein, and this more re-
uced conformation has a lower electrophoretic mobility
ecause it is less compact. Cell lysates were immuno-
recipitated with an Env-specific rabbit antiserum that
ecognizes early forms of gp160 particularly well. The
amples were analyzed with SDS–PAGE under nonre-
ucing and reducing conditions (Figs. 5C and 5D, re-
pectively). The nonreducing gel indicates that two Env
orms are predominantly present in the cell lysate of LAI
mmediately after the pulse (Fig. 5C, lane 1). These forms
epresent a relatively reduced, unfolded Env protein and
relatively mature Env form that contains disulfide
onds. The more reduced Env form was more prominent
n the LAIenv sample immediately after the pulse (Fig. 5C,
ane 6). Within a 1-h chase, the more reduced form of
p160 (LAI, lane 2) had disappeared almost completely
FIG. 6. Env mutations do not stimulate infection of SupT1 cells an
roduced in SupT1 (A and B) or C33A cells (C and D) were used to
ostinfection, reverse transcription products were detected by PCR
ybridization signals were quantitated with a PhosporImager and arend only the oxidized form of gp160 was visible. In vontrast, for LAIenv the reduced form of gp160 was still
etectable after $2 h of chase (lane 8), indicating that
isulfide bond formation was slower in LAIenv gp160 than
n LAI gp160. Under reducing conditions, the two Env
orms comigrated as reduced gp160 (Fig. 5D). Again,
educed processing of the LAIenv gp160 is apparent from
he decrease of the gp160 signal. Note that gp120 is not
ecognized by the antibody used in this experiment. In
ummary, formation of disulfide bonds, and therefore
olding of gp160, in addition to processing into gp120 and
p41 was less efficient for the mutant Env than for the
ild-type protein. This phenomenon was observed both
n SupT1 and C33A cells.
he mutant Env protein abolishes infection of non-
upT1 cells but does not improve SupT1 infection
Because the Env protein mediates the binding of the
irion to the host-cell receptors, we next examined the
ffect of the Env mutations on virus infectivity. Virions
roduced in SupT1 cells were harvested and quantitated
y CA-p24 ELISA. Equal amounts of LAI and LAIenv viri-
ns were used to infect SupT1 and C8166 cells. Infection
f these cells was monitored by detection of reverse
ranscription products at different times (0–4 h) postin-
ection. With SupT1 cells, cDNA products first were de-
ected 1 h after infection by the wild-type virus and
ncreased levels were observed over time (Fig. 6A, quan-
itated signals are shown in Fig. 7A). Although consider-
ble variation was observed for the different time sam-
les, we measured no significant difference for the two
IV-1 variants. In contrast, infection of the C8166 cells
ielded only cDNA products for the wild-type LAI virus
Figs. 6B and 7B). Even at 4 h p.i., no cDNA products
ould be detected for the mutant LAIenv. Apparently, the
utant virions cannot infect C8166 cells, which explains
he observed replication defect of the LAIenv and mLAIenv
sh infection of C8166 cells. Equal amounts of LAI and LAIenv virions
upT1 (A and C) or C8166 cells (B and D). At different times (0–4 h)
ualized on a Southern blot probed with a 32P-labeled HIV-1 probe.
ted in Fig. 7.d aboli
infect S
and visiruses on these cells (Fig. 2). Thus whereas the Env
m
a
C
C
t
T
C
a
r
m
a
v
a
(
p
R
E
t
t
S
a
o
c
o
i
o
v
w
i
c
t
e
S
d
t
f
e
s
f
E
t
p
t
w
on infe
62 DAS ET AL.utations do not affect infection of SupT1 cells, they
bolish infection of C8166 cells.
We also assayed the infectivity of virions produced by
33A non-T cells. Upon infection of C8166 cells with the
33A-produced virions, strongly reduced cDNA produc-
ion was measured for LAIenv mutant (Figs. 6D and 7D).
hus the Env mutations significantly reduced infection of
8166 cells, both for virions produced in T cells (SupT1)
nd non-T cells (C33A). Upon infection of SupT1 cells,
educed cDNA production was observed for the LAIenv
utant compared with the LAI wild-type virus (Figs. 6C
nd 7C). Thus SupT1 infectivity of the C33A-produced
irions is reduced by the Env mutations. Because such
n effect was not observed with SupT1-produced virions
Figs. 6A and 7A), this inhibitory effect is apparently
roducer-cell specific.
educed syncytium-inducing capacity of the mutant
nv protein
So far, we investigated several Env-mediated steps of
he viral replication cycle and found that the Env muta-
ions reduced folding and processing of gp160 in both
upT1 and C33A cells. Furthermore the Env mutations
bolished infection of C8166 cells and reduced infection
FIG. 7. The effect of the Env mutationsf SupT1 cells when virions were produced in C33A cells. These defects can explain the reduced replication
f Env-mutated virus on cells other than SupT1, but there
s no apparent explanation for the improved replication
n SupT1 cells. Both the assembly of SupT1-produced
irions and the infection of SupT1 cells by these virions
ere not affected by the Env mutations.
The HIV-1 LAI virus is able to induce syncytia, and
nfected SupT1 cells readily fuse to form multinucleated
ells. Thus the virus can spread in the culture not only by
he infection route but also by this cell-fusion route (Sato
t al., 1992). When culturing LAI and LAIenv viruses in
upT1 cells, we consistently observed that LAIenv pro-
uced approximately fivefold more progeny than LAI at
he peak of infection (Fig. 2, and results not shown). In
act, examination of these cultures revealed the pres-
nce of large syncytia in the LAI cultures and the ab-
ence of such large multinucleated cells in LAIenv-in-
ected cultures. We therefore examined the effect of the
nv mutations on cell fusion in single-cycle assays.
SupT1 cells that express wild-type or mutant Env pro-
ein and all other HIV-1 proteins (including Tat) were
roduced by transfection with pLAI or pLAIenv, respec-
ively. Two days after transfection, cells and supernatant
ere separated, and each was mixed with SupT1 cells
ction. See legend to Fig. 6 for details.ontaining a Tat-responsive LTR–CAT reporter gene con-
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63LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1truct. Upon fusion of Tat-expressing cells with these
eporter cells, the LTR promoter will be activated and
AT enzyme will be produced. Formation of syncytia was
nalyzed by light microscopy after 24 h and quantitated
y measurement of the CAT activity in cell extracts (Fig.
A). The cells expressing the wild-type Env protein fused
fficiently with the reporter cells, resulting in high CAT
evels. In contrast, for the cells expressing mutant Env,
o syncytia were observed and a low CAT level was
easured. Mixing the reporter cells with the virus-con-
aining supernatant did not result in CAT production,
ndicating that transmission of the Tat protein indeed
as mediated by cell fusion and not by virus infection.
In an alternative assay, SupT1 cells that express the
IV-1 Tat protein and either the wild-type or mutant Env
rotein were produced by transfection with pLAIDgagpol or
LAIDgagpol
env . These proviral constructs lack the gag/pol
enes and do not produce virions. These cells were
ixed with LTR–CAT-containing reporter cells. Syncytium
ormation was assayed after 24 and 48 h by light micros-
opy and by measuring the induction of CAT activity
Figs. 8B and 8C). Syncytium formation was not detected
ith the Env-mutated construct, whereas cells express-
ng wild-type Env produced large syncytia. Accordingly,
igh CAT activity levels were observed for the wild-type
nv constructs, whereas at least a 10-fold drop in activity
as measured for the mutant Env constructs. These
ombined results indicate that the Env mutations abolish
ell-fusion, which explains the absence of syncytia in
AIenv-infected cultures.
DISCUSSION
In this study, we analyzed in detail a variant of the
IV-1 LAI virus that was obtained upon prolonged culture
f a poorly replicating LAI mutant in the SupT1 T cell line
Das et al., 1998). Mutation of two highly conserved
mino acids within the C1 and C4 domain of the Env
rotein was found to be responsible for the improved
eplication in SupT1 cells. Interestingly, this adaptation to
he SupT1 T cell line coincided with a loss of infectivity in
ther T cell lines and primary cells. The restriction of the
ost range was not caused by a switch in coreceptor
sage, as both the LAI virus and the LAIenv variant were
ensitive to inhibition by the CXCR4-specific chemokine
DF-1. To identify which step of the viral replication cycle
as improved by the modified Env molecule, we ana-
yzed Env protein biosynthesis and Env-mediated virus
nfection. Surprisingly neither Env function was found to
e improved in SupT1 cells, and even minor defects
ere apparent for the mutant Env protein. Such defects
an explain the inability of this virus to replicate on other
ell types but do not explain the improved replication of
he LAIenv virus on SupT1 cells. The mutant Env protein
as found to exhibit a gross defect in mediating cellusion and the induction of large multinucleated syncytia. Lombining these results, we propose that the mutant
irus postpones the death of the infected host cell be-
ause syncytia are not formed, thereby increasing the
roduction of progeny. Consistent with this idea, no syn-
ytia were observed in SupT1 cultures infected with the
FIG. 8. Env mutations inhibit syncytia formation. (A) SupT1 cells were
ransfected with LAI, LAIenv, or pBluescript (mock). Two days after
ransfection, cells and supernatant were separated, and each was
ixed with SupT1 cells containing a Tat-responsive LTR–CAT reporter
ene construct. After 24 h, formation of syncytia was analyzed by light
icroscopy (1, syncytia; 2, no syncytia), and quantitated by measure-
ent of the CAT activity in cell extracts. (B and C) SupT1 cells were
ransfected with a Tat-expression vector and pLAIDgagpol (1 or 5 mg),
LAIDgagpol
env (1 or 5 mg), or no additional plasmid (mock). Two days after
ransfection, these cells were mixed with LTR–CAT-ransfected SupT1
ells. Syncytium formation was assayed after 24 (B) and 48 h (C).AIenv virus, and the final virus level in these cultures was
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64 DAS ET AL.pproximately fivefold higher than in cultures infected
ith the wild-type LAI virus. Apparently, lengthening the
eriod of virus production before the infected cell dies
an improve viral replication so efficiently that it even
escues replication of otherwise defective viruses (e.g.,
LAI). This evolutionary pathway demonstrates the del-
cate balance between viral replication rate and the del-
terious effect of the virus on the host cell. Moreover, our
n vitro evolution studies reveal that HIV-1 can evolve
oward a virus that is less cytopathic, in this case by
witching from the SI to the NSI phenotype. Please note
hat the SI-NSI nomenclature was based on infection
xperiments in SupT1 cells, whereas this phenotype is
efined based on infection of MT2 cells.
A general viral strategy is to protect the host cell from
eing killed too early, and the timing of cell death can be
n important determinant of viral replication. For in-
tance, adenoviruses increase their “burst size” by de-
aying death of the infected cell (Kirn et al., 1998). Be-
ause cellular defense mechanisms are designed to
emove infected cells, e.g., by means of programmed cell
eath, some viruses have evolved ways to actively coun-
eract these measures. Such viruses encode specific
roteins to suppress cell suicide, which would normally
urtail the infection (McFadden, 1998; Shisler et al.,
998). Furthermore virulent viruses evolve to become
elatively harmless to their host, as was described for the
ighly virulent myxomavirus that was introduced in Aus-
ralia to control rabbit populations (Fenner and Ratcliffe,
965). Similarly, simian immunodeficiency viruses (SIV),
hich have been in equilibrium with their simian hosts
or a much longer time than HIV with its human host,
ave evolved to a nonpathogenic state. The SI-inducing
IV-1 variants also may be suppressed in vivo because
f their cytopathicity. Indeed, SI variants are underrepre-
ented or not detectable in most HIV-infected individuals,
n particular in the asymptomatic phase of the infection
Fauci and Desrosiers, 1997). The preferential occur-
ence of NSI variants in transmission and in the early
ourse of HIV-infection has been suggested to reflect the
vailability of CCR51 cells at the site of transmission, as
here is some evidence that the initial target cell popu-
FIG. 9. HIV-1 evoluation during transmission consists of CCR51/CXCR42 cangerhans cells (Zaitseva and et al., 1997). The obser-
ation that HIV-1 does not evolve toward the SI pheno-
ype in some patients, and only partially and in a delayed
anner in other patients, may be related to the increased
ytopathicity of such variants.
The SI to NSI switch presented in this study seems to
ispute the general notion that primary HIV-1 isolates
sually change from the NSI to the SI phenotype both in
ivo and in cell culture. Several reports suggest that
aboratory adaptation involves an increased ability of the
irus Env molecule to interact with the CD4 receptor, and
his change usually coincides with an increase in syn-
ytium-inducing capacity (Fujita et al., 1992; Kozak et al.,
997; Moore and Ho, 1995). However, most of these
tudies do not test for virus adaptation, but rather repre-
ent selection schemes that favor outgrowth of the
XCR4/SI variants from the mixed quasispecies of a
rimary isolate (Fig. 9). Real adaptation studies are rare,
ut two previous studies did present a virus evolution
athway that is comparable with the one described in
his study. Prolonged passage of primary isolates in the
9 T cell line rendered the viruses sensitive to neutral-
zation by human sera, which coincided with reduced
ytopathicity (Wrin et al., 1995). A more detailed study
emonstrated adaptation of the ELI strain for growth on
cell lines, which resulted in a virus with a broadened
ost range and a reduced capacity for syncytium forma-
ion (Peden et al., 1991). Several amino acid substitutions
ere present in the selected Env protein, and the loss of
he SI phenotype was demonstrated to be mediated by
n E49G substitution in the fusion domain of gp41 (Kozak
t al., 1997). In general, the evolutionary route chosen by
virus will critically depend on the virus–host combina-
ion used. For instance, the selection of less virulent
IV-1 variants as described in this study will be seen
nly with virus–cell combinations that exhibit gross cy-
opathic effects. Alternative routes toward a less cyto-
athic variant are also possible, as exemplified by the
DK isolate that evolved a CD4-independent phenotype
pon prolonged culturing in vitro (Dumonceaux et al.,
998).
The LAI adaptation described in this study was
vivo and in vitro.aused by two mutations in conserved Env domains:
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65LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1436R in the C4 domain and, although to a lesser extent,
70T in the C1 domain. Each individual mutation was
ble to improve LAI replication on SupT1 cells. The same
wo Env mutations negatively affected replication on
ost other cell types (Table 1). Our combined results
uggest that alteration of one Env-mediated mechanism
s responsible for both improved replication in SupT1
ells and loss of function in other cells. The ELI adapta-
ion experiment mentioned above (Peden et al., 1991;
ozak et al., 1997) yielded an Env protein variant with
roadened host range and increased affinity for CD4.
his phenotype was determined by acquisition of a
427R mutation, and this C4 amino acid corresponds to
AI position E434, which is in close proximity to the G436
osition that was found to be altered in this study. Be-
ause the C4 region has been implicated as a contact
ite for CD4 (Lasky et al., 1987; Cordonnier et al., 1989;
lshevsky et al., 1990; Robey et al., 1996), these changes
ay directly affect the ability of Env to interact with CD4
nd thereby influence the cell–cell and virus–cell inter-
ctions. The X-ray structure of the HIV-1 Env protein
Kwong et al., 1998; Rizzuto et al., 1998) is consists with
his possibility because amino acid 436 is located within
he CD4 binding domain. We measured a dramatic loss
f cell-fusion capacity of the Env variant in SupT1 cells,
nd the infectivity of these virions was severely affected
n all other T cell lines and primary cells. Alternatively, the
4 and C1 mutations may affect the Env-CD4 interaction
n a more indirect manner through an effect on the
olding of this complex glycoprotein. For instance, there
s ample evidence for complex intramolecular interac-
ions within the Env protein, and the C4 domain has been
eported to interact with the V1/V2 and V3 domains
Willey et al., 1989; Freed and Martin, 1995; Wang et al.,
996). The observation of a partial folding/processing
efect of the mutant Env protein (Figs. 4 and 5) may be
ndicative of such an effect.
The results presented in this study underscore the
otion that HIV-1 Env-mediated phenotypic changes can
ary significantly among different host cell types. The
AIenv variation influenced virus production in SupT1 cul-
ures in a positive manner, whereas strong negative
ffects were scored in all other cell types. The deleteri-
us effects seen in most cells are most likely due to the
ompromised infection function of the Env protein. We
hink that this same Env molecule can be beneficial in
upT1 cells for two reasons. First, the loss of infection
unction is not apparent in SupT1 cells, although the
nfection efficiency was not improved either. Second,
irus production is significantly increased due to re-
uced cell death. We do not currently understand what is
pecial about the SupT1 T cell line such that it is less
ensitive to the reduced infection capacity of the modi-
ied Env protein. It could be high surface expression of
he CD4 receptor on SupT1 cells somehow can bypass
he requirement for an optimally active Env protein for Hirus infection. Indeed, FACS analysis indicated the high-
st CD4 staining of SupT1 cells among the panel of T cell
ines used in this study: SupT1 (mean intensity 29.3) .
T2 (21.3) . A3.01 (15.4) . C8166 (12.4) (see also Koken
nd Berkhout, 1994). We cannot exclude either that the
D4 or CXCR4 receptor of SupT1 cells contains a unique
utation that triggered adaptation of the viral Env pro-
ein. Also an as yet unidentified accessory component of
he cell membrane may interact with Env and thereby
nfluence virus infection in a cell-type-specific manner.
The Env variant efficiently infected SupT1 cells but
emonstrated a complete loss of cell-fusion capacity.
pparently, we could separate the role of Env in virus
nfection (virus–cell fusion) from its role in syncytium
ormation (cell–cell fusion), indicating that the two mech-
nisms are dissimilar. This is supported by a micro-
copic study that followed the redistribution of fluores-
ent dyes, which demonstrated that the process of Env-
nduced cell–cell fusion occurs much more slowly than
irus–cell fusion (Dimitrov and Blumenthal, 1994).
In summary, it turns out that we have selected for a
irus that acquired increased fitness on SupT1 cells by
eans of a loss of Env function. This expertise may help
s design new evolutionary strategies that will allow the
election of altered Env molecules that exhibit a gain of
unction. They may be used to target new cell types
hrough binding of Env to novel coreceptors or through
irus entry in a CD4-independent manner. The use of an
IV-1 Env protein with a modified host cell range can add
ertain safety features to live attenuated HIV-1 vaccines.
odified Env reagents also may be useful in gene ther-
py protocols to target-specific host cells with HIV-based
ectors (Naldini et al., 1996). It is clear that optimized
irus–host systems may provide efficient means to pro-
uce high amounts of virus. As an example, we routinely
each amounts of virus of #10.000 ng/ml CA-p24 in
upT1 cultures infected with the LAIenv variant, which to
ur knowledge is significantly higher than any previously
eported level of virus production.
MATERIALS AND METHODS
NA constructs
The full-length molecular clone pLAI (Peden et al.,
991) of the HIV-1 isolate LAI (Wain-Hobson et al., 1985,
991) was used to produce wild-type and mutant viruses.
ucleotide numbers refer to the LAI proviral DNA, with
osition 1 being the first nucleotide of the 59 LTR. One
equence difference was found between the pLAI mo-
ecular clone that we used and the published LAI se-
uence (GenBank Accession No. K02013) at position
868–7869 (GC instead of the reported sequence CG),
hanging Env amino acid 538 from Arginine (R) to Ala-
ine (A) (Das et al., 1998). The sequence of pLAI at this
osition now conforms to the consensus sequence for
IV-1 type B (Myers et al., 1995). Construction of the
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66 DAS ET AL.LAI mutant, in which a short open reading frame had
een introduced in the leader region of the HIV-1 tran-
cript, was described previously as the uAUG mutant
Das et al., 1998).
Selection of the variant Env protein by culturing of the
LAI virus on SupT1 cells for 110 days and introduction
f the mutant env gene in pLAI were described previ-
usly (Das et al., 1998). In the pLAIenv and mLAIenv plas-
ids, nearly the complete env gene of the adapted HIV-1
ariant had been inserted as a SalI-BamHI fragment
position 5821–8522). In addition, we constructed a set of
ive subclones with small portions of the env gene (Das
t al., 1998). Fragment A (SalI-NdeI, position 5821–6435)
ontains the Env I24T substitution; fragment B (NdeI-
heI, position 6435–7307) encodes the A70T change in
he C1 domain, fragment C (NheI-MfeI, position 7307–
702) encodes the C4 mutation G436R and a silent
odon change, fragment D (MfeI-HindIII, position 7702–
188) contains two silent Env codon changes, and frag-
ent E (HindIII-BamHI, position 8188–8522) has a A705V
ubstitution in the transmembrane domain.
The Env-expression vector pLAIDgagpol was derived from
LAI by deletion of the gag-pol domain by ClaI-NcoI
igestion (position 829–5710), filling-in of the recessive
nds with Klenow DNA polymerase in the presence of
NTPs, and religation of the vector. The same strategy
as used to convert pLAIenv into pLAIDgagpol
env . The LTR–CAT
eporter plasmid and pcDNA3-Tat expression vector
sed in the cell-fusion assays were described previously
Verhoef et al., 1997).
ells, DNA transfection, and virus infection
T cell lines (SupT1, MT-2, C8166, A3.01) were grown in
PMI 1640 medium containing 10% fetal calf serum (FCS)
t 37°C and 5% CO2. Donor PBMC were prepared and
ultured as previously described (Back et al., 1996). Cells
ere transfected with HIV-1 molecular clones by means
f electroporation. Briefly, 5 3 106 cells were washed in
PMI 1640 with 20% FCS, mixed with 1–5 mg DNA in 0.4
m cuvettes and electroporated at 250 V and 960 mF,
ollowed by resuspension of the cells in RPMI 1640 with
0% FCS. T cell lines and PBMC were split twice a week
1–10 and 1–2, respectively). To monitor virus production,
he CA-p24 level in the culture supernatant was mea-
ured by ELISA (Abbott) as described previously (Back et
l., 1996).
C33A cervix carcinoma cells (ATCC HTB31) (Auer-
perg, 1964) were grown as a monolayer in Dulbecco’s
odified Eagles medium (DMEM) supplemented with
0% FCS and MEM nonessential amino acids at 37°C
nd 5% CO2. C33A cells were transfected by the calcium
hosphate method. Cells were grown to 60% confluency
n 24-well multidish plates or 75-cm2 cell-culture flasks.
or transfection of the 24-well plates, 1 mg DNA in 22 ml
ater was mixed with 25 ml 2[mult] HBS (50 mM HEPES qH 7.1, 250 mM NaCl, 1.5 mM Na2HPO4) and 3 ml 2 M
aCl2. For transfection of 75-cm
2 flasks, 40 mg DNA in
80 ml water was mixed with 1 ml 23 HBS and 120 ml 2
CaCl2. The mixtures were incubated at room temper-
ture for 20 min and subsequently added to the culture
edium. The culture medium was changed after 16 h.
hemokine inhibition assays
To measure the effect of the chemokine SDF-1 on the
eplication of LAI and LAIenv virus, the corresponding
olecular clones were transfected into SupT1 cells. Vi-
uses produced at 3 days posttransfection were quanti-
ated by CA-p24 ELISA, and equal amounts of virus (0.5
r 5 ng CA-p24) were added to 1 3 106 SupT1 cells in the
resence or absence of 100 nM SDF-1 1–67 (Bleul et al.,
996; Oberlin et al., 1996). This synthetic peptide was
indly provided by Dr. Ian Clark-Lewis, University of Brit-
sh Columbia, Vancouver. Cells were incubated at 37°C
nd 5% CO2 for 2 h, washed twice with 8 ml phosphate-
uffered saline (PBS; 10 mM Na-phosphate pH 7.4, 150
M NaCl) and once with 2 ml complete medium with or
ithout SDF-1, and then cultured for 6 days in 1.5 ml of
he same medium.
everse transcription analysis upon infection
f T cells
Virus stocks were prepared by transfection of C33A or
y infection of SupT1 cells. Three days posttransfection
f C33A cells and 4 days p.i. of SupT1 cells, the culture
edium was centrifuged at 4000 rpm for 30 min to
emove cells. The virus-containing supernatant was sub-
equently filtered through a 0.45-mm-pore-size filter
Schleicher and Schuell) and stored at 270°C. Contam-
nating DNA present in this supernatant was digested by
ncubation with 50 U DNaseI (RNase-free, Boehringer
annheim) per ml and 10 mM MgCl2 at 37°C for 1 h.
upT1 or C8166 cells (8 3 106 cells in 5 ml medium) were
ncubated with equal amounts of wild-type and mutant
iruses (normalized by CA-p24 levels: 250 ng for C33A-
roduced virus, 4 ng for SupT1-produced virus) for 1 h at
7°C. A control sample was incubated at 0°C to prevent
everse transcription. Viruses were removed by exten-
ive washing in medium. The cells that had been incu-
ated at 37°C were either harvested directly (1 h sample)
r incubated for an additional 1–3 h (2-, 3-, and 4-h
amples). The control cells that had been incubated at
°C were harvested directly (0-h sample). Infected cells
ere made into pellets by centrifugation at 4000 rpm for
min and washed with PBS buffer. DNA was solubilized
y resuspending the cells in 10 mM Tris–HCl (pH 8.0), 1
M EDTA, 0.5% Tween 20, followed by incubation with
00 mg Proteinase K per ml at 56°C for 30 min and at
5°C for 10 min. Reverse transcription products were
mplified by PCR with a 59 primer identical to tat se-
uences (KV1, position 5821/5839) and a 39 primer com-
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67LOSS OF SYNCYTIUM-INDUCING PROPERTIES UPON LABORATORY ADAPTATION OF HIV-1lementary to env sequences (WS3, position 6579/6598).
CR products were analyzed by agarose gel electro-
horesis and Southern-blotted onto nylon membrane
Zeta probe, Bio-Rad). To quantitate the PCR products,
he filters were hybridized with a 32P-labeled HIV-1 probe
LAI positions 5821/6379) in 0.5 M Na-phosphate (pH
.2), 7% SDS, 1 mM EDTA and 50 mg salmon testis DNA
er ml at 65°C for 16 h. Membranes were washed in 40
M Na-phosphate (pH 7.2), 1% SDS at 65°C, three times
or 5 min and once for 15 min and for 5 min in the same
uffer at room temperature. Hybridization signal were
uantitated with a PhosphorImager (Molecular Dynam-
cs).
ell-fusion assays
In the assay shown in Fig 6A, SupT1 cells (5 3 106)
ere transfected with 5 mg pLAI, pLAIenv, or the control
lasmid Bluescript. The cells were cultured for 2 days,
nd cells and supernatant were separated by centrifu-
ation at 1200 rpm for 10 min. Both cell and supernatant
amples were mixed with a SupT1 culture that was
ransfected the previous day with 5 mg LTR–CAT reporter.
aquinavir (1 mM) was added after 1 h to inhibit subse-
uent rounds of viral replication. Cells were cultured for
4 h, and intracellular CAT activity was measured as
escribed (Verhoef et al., 1997).
In the assay shown in Figs. 6B and 6C, 5 3 106 SupT1
ells were transfected with 5 mg pcDNA3Tat and 0, 1, or
mg pLAIDgagpol or pLAIDgagpol
env . The cells were cultured for
days, washed, and mixed with LTR–CAT-transfected
upT1 cells (see above). Cells were cultured and intra-
ellular CAT activity was measured after 24 and 48 h.
estern blot analysis
C33A cells were transfected with the proviral clones.
t 3 days posttransfection, cells were trypsinized and
ollected by low-speed centrifugation (1500 rpm, 10 min).
elleted cells were washed with PBS buffer and resus-
ended in reducing SDS sample buffer (50 mM Tris–HCl
H 7.0, 2% SDS, 10% b-mercaptoethanol, 5% glycerol).
roteins were resolved in a 10% SDS–polyacrylamide gel
nd transferred to an Immobilon-P membrane (16 h, 60
). The membrane was blocked with PBS containing 5%
onfat dry milk, 3% BSA, and 0.05% Tween 20 and sub-
equently incubated with the monoclonal anti-Env anti-
ody ADP332 (Thiriart et al., 1989) (dilution 1 in 100) for
h at room temperature, washed, incubated with rabbit
nti-mouse IgG-alkaline phosphatase conjugate (Bio-
ad), and developed with the 5-bromo-4-chloro-3-in-
olylphosphate/nitroblue tetrazolium protocol (Sigma).
etabolic labeling and immunoprecipitations
SupT1 cells (15 3 106) were transfected with 15 mg
LAI or pLAIenv and cultured in 15 ml medium for 2 days.
ells were centrifuged at 1200 rpm for 10 min and Rashed with 30 ml PBS buffer. Cells were starved for 15
in at 37°C in 10 ml methionine/cysteine-free RPMI 1640
edium with 10 mM HEPES pH 7.4. The cells were
entrifuged and resuspended in 150 ml of the same,
rewarmed medium. Pulse-labeling was started by ad-
ition of 250 mCi [35S]methionine/cysteine (1000 Ci/
mol, Amersham), and cells were incubated for 30 min
t 37°C. Radiolabeled proteins were chased by addition
f 1500 ml prewarmed RPMI 1640 medium, supple-
ented with 5 mM methionine, 5 mM cysteine, 20 mM
EPES pH 7.4, and 0.5 mM cycloheximide. Samples (300
l) were taken at various times and placed on ice. Cells
ere collected by centrifugation (6 s in Eppendorf cen-
rifuge at maximum speed), lysed in 600 ml of 1% Triton
-100 in MNT (20 mM MES, 100 mM NaCl, and 30 mM
ris–HCl pH 7.4), containing protease inhibitors (chymo-
tatin, leupeptin, antipain, pepstatin, PMSF, and EDTA)
nd 20 mM iodoacetamide to block free sulfhydryl
roups (Braakman et al., 1991). Virus-containing super-
atant samples were lysed by addition of an equal vol-
me of 2[mult] concentrated lysis buffer.
The Env protein was immunoprecipitated at 4°C from
ell lysates (75–150 ml per sample) and medium lysates
400 ml per sample) as described (Braakman et al., 1991),
sing either an antiserum from an HIV-1-infected individ-
al or a rabbit antiserum raised against HIV-1 LAI Env.
mmunoprecipitates were washed twice at room temper-
ture, once with 150 mM NaCl and 1 mM EDTA in 10 mM
ris–HCl pH 8.0, once with 0.1% SDS, 0.05% Triton X-100,
nd 300 mM NaCl in 10 mM Tris–HCl pH 8.6. One portion
f the immunoprecipitates was treated with endoglyco-
idase F. All samples were analyzed using nonreducing
nd reducing SDS–PAGE (7.5%) followed by fluorography
s described before (Braakman et al., 1991).
ndoglycosidase F treatment
The pellet from the washed immunoprecipitates was
esuspended in 15 ml of 0.2% SDS in 100 mM sodium
cetate pH 5.5 and heated to 95°C for 5 min. After
ooling, an equal volume of 100 mM sodium acetate pH
.5 was added and the sample was incubated for 90 min
t 37°C with 0.025 U of endoglycosidase F (Boehringer
annheim). Laemmli sample buffer was added to a final
oncentration of 1.5% SDS, 10% glycerol, 0.004% brom-
henol blue in 200 mM Tris–HCl pH 6.8.
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